Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. World Health Organization. Breast cancer [Internet].2021 cited 2022 May 2. Available from https://www.who.int/news-room/fact-sheets/detail/breast-cancer
2. Arthur LM, Turnbull AK, Khan LR, Dixon JM (2017) Pre-operative endocrine therapy. Curr Breast Cancer Rep 9:202–209. https://doi.org/10.1007/s12609-017-0255-6
3. Zhang J, Yang C, Lei C, Zhang Y, Ji F, Gao H et al (2021) Survival outcomes after breast-conserving therapy compared with mastectomy for patients with early-stage metaplastic breast cancer: a population-based study of 2412 patients. Breast 58:10–17. https://doi.org/10.1016/j.breast.2021.03.010
4. Freelander A, Brown LJ, Parker A, Segara D, Portman N, Lau B, Lim E (2021) Molecular bomarkers for contemporary therapies in hormone receptor-positive breast cancer. Genes 12:285. https://doi.org/10.3390/genes12020285
5. Chien TJ (2021) A review of the endocrine resistance in hormone-positive breast cancer. Am J Cancer Res 11:3813–3831